VERBESSERTE ALPHAVIRUS REPLIKONS UND HELFERKONSTRUKT

European patent · EP1608762 · Deleted

Register entry

Publication number
EP1608762
Application number
EP04757890
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Mar 19, 2004
Published
Dec 28, 2005
Granted
Jan 8, 2014
Deleted
Mar 19, 2024
Reason
Maximum term reached
IPC classes
C12N 15/86 (2006.01)
A61K 35/76 (2006.01)
C07K 14/18 (2006.01)
Priority
US 456196 P 20.03.2003
PCT application
PCT/US2004/008458 19.03.2004
PCT publication
WO2004/085660 07.10.2004
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 19, 2024

    Maximum term reached

    Published in Swissreg on 19.03.2024

  2. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  3. Mar 29, 2014

    Agent entered

    Representative
    Meyer & Kollegen, Ringstrasse 35c, 7000 Chur

    Published in Swissreg on 29.03.2014

  4. Jan 8, 2014

    Granted

    Published in Swissreg on 08.01.2014

Parties

Holder

AlphaVax, Inc.

Alphavax, Inc.

P.O. Box 110307, 2 Triangle Drive, Research Triangle Park, NC 27709-0307, US

Agent

Meyer & Kollegen

Ringstrasse 35c, 7000 Chur

Inventor

SMITH, Jonathan, F.

Cary, NC 27511, US

KAMRUD, Kurt

Apex, NC 27502, US

RAYNER, Jon, O.

Olathe, Kansas 66062, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.